Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19

MLA

Havervall, Sebastian, et al. Robust Humoral and Cellular Immune Responses and Low Risk for Reinfection at Least 8 Months Following Asymptomatic to Mild COVID-19. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1280632952&authtype=sso&custid=ns315887.

APA

Havervall, S., Ng, H., Jernbom Falk, A., Greilert-Norin, N., Månberg, A., Marking, U., Laurén, I., Gabrilesson, L., Salomonsson, A.-C., Aguilera, K., Kihlgren, M., Månsson, M., Rosell, A., Hellström, C., Andersson, E., Olofsson, J., Skoglund, L., Yousef, J., Pin, E., … Thålin, C. (2022). Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Chicago

Havervall, Sebastian, Henry Ng, August Jernbom Falk, Nina Greilert-Norin, Anna Månberg, Ulrika Marking, Ida Laurén, et al. 2022. “Robust Humoral and Cellular Immune Responses and Low Risk for Reinfection at Least 8 Months Following Asymptomatic to Mild COVID-19.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1280632952&authtype=sso&custid=ns315887.